Skip to main content

Francina Munell Casadesus

Institutions of which they are part

Main researcher
Pediatric Neurology
Vall Hebron Institut de Recerca

Francina Munell Casadesus

Institutions of which they are part

Main researcher
Pediatric Neurology
Vall Hebron Institut de Recerca

Projects

accions dels estrògens en el desenvolupament i en la progressió cap a l'hormonoresistència en el càncer de pròstata

IP: Francina Munell Casadesus
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13200
Reference: PRED/IR-HUVH/41/20040,
Duration: 01/01/2006 - 31/12/2008

Acciones de la forma alternativa de la proteína transportadora de esteroides sexuales (SHBGalt) en fertilidad masculina y en cáncer de prostata humanos

IP: Francina Munell Casadesus
Collaborators: Tomàs Pinós Figueras
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: BEFI_01/9425
Duration: 26/09/2002 - 30/09/2005

Estudio de la expresión de la proteína transportadora de hormonas esteroideas sexuales (SHBG) y de los receptores de estrógenos beta (ERß) durante la espermatogénesis y su posible implicación en los trastornos de fertilidad masculina.

IP: Francina Munell Casadesus
Collaborators: -
Funding agency: Serono España SA
Funding: 18030
Reference: SERONO/01/02
Duration: 01/02/2002 - 31/01/2005

Xarxa d'estudi de la patologia prostàtica humana

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Inés de Torres Ramirez, Francina Munell Casadesus, Tomàs Pinós Figueras, Anna Santamaria Margalef
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 6010.12
Reference: 2001XT00067
Duration: 01/01/2002 - 26/02/2004

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Camacho Arteaga, Lina Fernanda

Camacho Arteaga, Lina Fernanda

Research technician
Clinical Pharmacology
Read more
Edo Salvador, Angel

Edo Salvador, Angel

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Lopez Peñuela, Nuria

Lopez Peñuela, Nuria

Multidisciplinary Nursing Research Group
Read more
Gliga , Otilia

Gliga , Otilia

Predoctoral researcher
Headache and Neurological Pain
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.